Follow
Yassen Assenov
Yassen Assenov
Group Leader
No verified email - Homepage
Title
Cited by
Cited by
Year
Maftools: efficient and comprehensive analysis of somatic variants in cancer
A Mayakonda, DC Lin, Y Assenov, C Plass, HP Koeffler
Genome research 28 (11), 1747-1756, 2018
32072018
Computing topological parameters of biological networks
Y Assenov, F Ramírez, SE Schelhorn, T Lengauer, M Albrecht
Bioinformatics 24 (2), 282-284, 2008
18472008
Comprehensive analysis of DNA methylation data with RnBeads
Y Assenov, F Müller, P Lutsik, J Walter, T Lengauer, C Bock
Nature methods 11 (11), 1138-1140, 2014
6752014
Topological analysis and interactive visualization of biological networks and protein structures
NT Doncheva, Y Assenov, FS Domingues, M Albrecht
Nature protocols 7 (4), 670-685, 2012
5142012
A DNA methylation fingerprint of 1628 human samples
AF Fernandez, Y Assenov, JI Martin-Subero, B Balint, R Siebert, ...
Genome research 22 (2), 407-419, 2012
4832012
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
S Moran, A Martínez-Cardús, S Sayols, E Musulén, C Balañá, ...
The Lancet Oncology 17 (10), 1386-1395, 2016
4662016
Mutational dynamics between primary and relapse neuroblastomas
A Schramm, J Köster, Y Assenov, K Althoff, M Peifer, E Mahlow, ...
Nature genetics 47 (8), 872-877, 2015
3812015
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
CC Oakes, M Seifert, Y Assenov, L Gu, M Przekopowitz, AS Ruppert, ...
Nature genetics 48 (3), 253-264, 2016
3312016
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
J Sandoval, J Mendez-Gonzalez, E Nadal, G Chen, FJ Carmona, ...
Journal of Clinical Oncology 31 (32), 4140-4147, 2013
3122013
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats
D Brocks, CR Schmidt, M Daskalakis, HS Jang, NM Shah, D Li, J Li, ...
Nature genetics 49 (7), 1052, 2017
2872017
Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer
D Brocks, Y Assenov, S Minner, O Bogatyrova, R Simon, C Koop, ...
Cell reports 8 (3), 798-806, 2014
2722014
RnBeads 2.0: comprehensive analysis of DNA methylation data
F Müller, M Scherer, Y Assenov, P Lutsik, J Walter, T Lengauer, C Bock
Genome biology 20 (1), 1-12, 2019
2592019
Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories
C Gerhauser, F Favero, T Risch, R Simon, L Feuerbach, Y Assenov, ...
Cancer Cell 34 (6), 996-1011. e8, 2018
2512018
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
Nature Biotechnology 34, 726-737, 2016
250*2016
The implications of alternative splicing in the ENCODE protein complement
ML Tress, PL Martelli, A Frankish, GA Reeves, JJ Wesselink, C Yeats, ...
Proceedings of the National Academy of Sciences 104 (13), 5495-5500, 2007
2492007
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia
CC Oakes, R Claus, L Gu, Y Assenov, J Hüllein, M Zucknick, M Bieg, ...
Cancer discovery 4 (3), 348-361, 2014
1632014
Strategies for analyzing bisulfite sequencing data
K Wreczycka, A Gosdschan, D Yusuf, B Gruening, Y Assenov, A Akalin
Journal of biotechnology 261, 105-115, 2017
1592017
A promoter DNA demethylation landscape of human hematopoietic differentiation
V Calvanese, AF Fernández, RG Urdinguio, B Suárez-Alvarez, C Mangas, ...
Nucleic acids research 40 (1), 116-131, 2012
1282012
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
DB Lipka, T Witte, R Toth, J Yang, M Wiesenfarth, P Nöllke, A Fischer, ...
Nature communications 8 (1), 2126, 2017
1182017
Random forest-based modelling to detect biomarkers for prostate cancer progression
R Toth, H Schiffmann, C Hube-Magg, F Büscheck, D Höflmayer, ...
Clinical epigenetics 11 (1), 148, 2019
1022019
The system can't perform the operation now. Try again later.
Articles 1–20